Takeuchi Akihiko, Yamamoto Norio, Hayashi Katsuhiro, Miwa Shinji, Takahira Masayuki, Fukui Kiyokazu, Oikawa Taku, Tsuchiya Hiroyuki
Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa-shi, 920-8641, Ishikawa-ken, Japan.
Department of Ophthalmology, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa-shi, 920-8641, Ishikawa-ken, Japan.
BMC Musculoskelet Disord. 2016 Apr 26;17:180. doi: 10.1186/s12891-016-1050-7.
A tenosynovial giant cell tumor (T-GCT) is a benign synovial tumor arising from the synovium, bursae, or tendon sheath. It can be intra- or extra-articular and localized or diffuse. Diffuse T-GCT is considered as a locally aggressive. Positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose with computed tomography (FDG PET/CT) is widely used to differentiate malignant from benign tumors and to detect distant metastasis. However, FDG PET/CT is limited by false-positive findings. In this study, we present two cases of T-GCT that developed in unusual locations and were confused with malignant tumors. The final diagnoses were histologically confirmed as T-GCTs.
Case 1. A 45-year-old Japanese female presented with a left choroidal melanoma and an abnormal lesion adjacent to the first cervical (C1) lamina confirmed by a PET scan (maximum standardized uptake value [SUVmax] =9.9 g/ml). MRI of the neck also detected a soft tissue mass (14.6 × 7.7 × 7 mm) adjacent to the C1 lamina. The choroidal melanoma was treated by heavy carbon ion radiotherapy. Although the size of the C1 soft tissue tumor remained unchanged, a CT-guided biopsy confirmed the diagnosis of the neck mass as a T-GCT. Case 2. A 15-year-old Japanese male with multiple type 1 neurofibromatosis presented with a soft tissue mass (26.1 × 24.7 × 11.5 mm) of the extra-articular hip joint that was coincidentally detected by FDG PET/CT during examination of a mediastinal soft tissue mass. SUVmax of the mediastinal lesion was 2.6 g/ml and of the hip lesion was 12.8 g/ml. Thus, differentiation from a malignant tumor, such as a malignant peripheral nerve sheath tumor, was necessary. An open biopsy was performed, and the frozen section was diagnosed as T-GCT. The tumor was excised, and the final histological diagnosis confirmed T-GCT.
T-GCT can show high FDG uptake, which might be confused with malignancy. Although MRI findings and location might help in the diagnosis of a T-GCT, careful assessment is mandatory, especially in unusual locations.
腱鞘巨细胞瘤(T-GCT)是一种起源于滑膜、滑囊或腱鞘的良性滑膜肿瘤。它可以位于关节内或关节外,可为局限性或弥漫性。弥漫性T-GCT被认为具有局部侵袭性。氟-18氟脱氧葡萄糖正电子发射断层扫描(PET)联合计算机断层扫描(FDG PET/CT)被广泛用于鉴别良恶性肿瘤及检测远处转移。然而,FDG PET/CT存在假阳性结果的局限性。在本研究中,我们报告了两例发生于不寻常部位且被误诊为恶性肿瘤的T-GCT病例。最终诊断经组织学证实为T-GCT。
病例1。一名45岁日本女性,患有左脉络膜黑色素瘤,PET扫描证实第一颈椎(C1)椎板旁有一异常病变(最大标准化摄取值[SUVmax]=9.9 g/ml)。颈部MRI也检测到C1椎板旁有一软组织肿块(14.6×7.7×7 mm)。脉络膜黑色素瘤接受了重离子放射治疗。尽管C1软组织肿瘤大小未变,但CT引导下活检确诊颈部肿块为T-GCT。病例2。一名15岁患有多发性1型神经纤维瘤病的日本男性,在检查纵隔软组织肿块时,FDG PET/CT偶然发现关节外髋关节处有一软组织肿块(26.1×24.7×11.5 mm)。纵隔病变的SUVmax为2.6 g/ml,髋关节病变的SUVmax为12.8 g/ml。因此,有必要与恶性肿瘤如恶性周围神经鞘瘤进行鉴别。进行了开放性活检,冰冻切片诊断为T-GCT。肿瘤被切除,最终组织学诊断证实为T-GCT。
T-GCT可表现出高FDG摄取,这可能会与恶性肿瘤混淆。尽管MRI表现和部位可能有助于T-GCT的诊断,但必须进行仔细评估,尤其是在不寻常部位。